REQUEST A DEMO
Total
USD $0.00
Search more companies

Radiance Bio-Synthetics Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Radiance Bio-Synthetics Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Radiance Bio-Synthetics Private Limited is a company based in India, with its head office in Thane. It operates in the Pharmaceutical and Medicine Manufacturing industry. Radiance Bio-Synthetics Private Limited was incorporated on April 12, 2005. In its most recent financial highlights, the company reported a net sales revenue increase of 13.69% in 2025. Its’ total assets recorded a negative growth of 9.21%. In 2025, Radiance Bio-Synthetics Private Limited’s net profit margin increased by 1.55%.

Legal Address
303 Radharesidence Sector 8B Cbd Belapur
Thane; Maharashtra; Postal Code: 400614

Contact Details: Purchase the Radiance Bio-Synthetics Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Radiance Bio-Synthetics Private Limited report to view the information.
Financial Auditors:
Purchase the Radiance Bio-Synthetics Private Limited report to view the information.
Incorporation Date:
April 12, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Radiance Bio-Synthetics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
13.69%
Total Operating Revenue
13.7%
Operating Profit
89.88%
EBITDA
91.97%
Net Profit/Loss for the Period
463.99%
Total Assets
-9.21%
Total Equity
8.51%
Operating Profit Margin
1.63%
Net Profit Margin
1.55%
Return on Equity (ROE)
6.33%
Debt / Equity
-42.73%
Quick Ratio
-0.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?